Eyepoint Pharmaceuticals Inc (EYPT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $17.86
• Market Cap: $1.47B
• EPS: $-3.00
• 52-Week High: $19.11
• 52-Week Low: $3.91

Market Sentiment

Eyepoint Pharmaceuticals Inc currently has a Bullish sentiment score of 0.21.

About Eyepoint Pharmaceuticals Inc

EyePoint Pharmaceuticals, Inc. is a pioneering biopharmaceutical company based in Watertown, Massachusetts, dedicated to developing innovative therapeutics for serious ocular diseases. Utilizing its proprietary micro-insert technology, the company specializes in sustained-release drug delivery systems designed to meet significant unmet medical needs in ophthalmology. With a robust pipeline targeting conditions such as retinal diseases, EyePoint is strategically poised for growth in major mark...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Eyepoint Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EYPT pay dividends?

Eyepoint Pharmaceuticals Inc (EYPT) does not currently pay a regular dividend.

What is EYPT's market cap?

Eyepoint Pharmaceuticals Inc (EYPT) has a market capitalization of $1.47B with a current stock price of $17.86.